
    
      To determine the effect of rosuvastatin on plasma lipids, lipoproteins, and endothelial
      function in HIV-infected patients on stable lopinavir/ritonavir therapy and to evaluate the
      safety of combined use of rosuvastatin and lopinavir/ritonavir. Also to determine the effect
      of lopinavir/ritonavir on the pharmacokinetics of rosuvastatin compared to historical
      controls an to determine the effect of rosuvastatin on the pk of lopinavir/ritonavir compared
      to historical controls and by intrapatient comparison.
    
  